Get Back To Work Already!
From Ticker Sense With the market pricing in virtually no chance of any Fed actions between now and at least September, we wonder if being a Fed official is one of the cushier jobs…
All Work
Douglas A. McIntyre
How Long Since a 2% One-Day Gain?
From Ticker Sense In the comments section of our recent post on the record number of days since we’ve had a one-day 2% decline in the S&P 500, a reader asked how long it…
TPX: Tempur-Pedic Not Resting on its Laurels
By William Trent, CFA of Stock Market Beat Mattress maker Tempur-Pedic (TPX) has had a busy few days. In addition to being included in our Small Cap and Mid Cap Watch Lists, introduced a…
OLN: Olin Corporation Earnings Tough To Estimate – Even for Management
By William Trent, CFA of Stock Market Beat Olin Corporation (OLN) reported earnings tonight, and the report was a doozy. Joseph D. Rupp, Chairman, President, and Chief Executive Officer said, “I am pleased to…
XRX: Xerox and the Spirit of Honest Debate
By William Trent, CFA of Stock Market Beat In response to our somewhat heated reaction to Xerox’ (XRX) earnings report, a Xerox employee submitted a comment outlining the Xerox perspective. Since the company appears…
Monday’s Top Biotech and Medical Stocks
From BioHealth Investor Biotechnology NEURO-HITECH INC +17.36% LEV PHARMACEUTICALS +11.18% OBAGI MEDICAL +9.16% GENVEC INC +7.84% ACHILLION PHARMACEUT +6.71% Diagnostic Substances SCOLR PHARMA INC +8.00% LEXICON GENETICS I +6.97% ASPENBIO PHARMA INC +6.12% ABAXIS…
Biotechs Ahead of Pharmas after All?
by H.S. AyoubBioHealth Investor.com In an earlier article, I reviewed Pisano’s book Science Business: the Promise, the Reality, and the Future of Biotech, in which the Harvard business professor provides compelling evidence showcasing the…
Analyzing Verizon (VZ) & Telco Industry
By Yaser Anwar, CSC of Equity Investment Ideas VZ’s results were in line with The Street’s expectations. VZ earned $1.03 billion in Q4 of 06 vs $1.66 billion in Q4 2005. Verizon Wireless added…
Monday Night Cramer Wrap-Up
Stock Tickers: DGX, AMGN, VFC, JSDA, HANS, GPS, HD, KR, WMT Last night on CNBC’s MAD MONEY, Jim Cramer reviewed Several "fallen angel" stocks where darling stocks have fallen more than they should have. …
Cramer Jonesing on Jones Soda (JDSA)
Cramer interviewed the CEO of Jones Soda (JSDA-NASDAQ) before ending MAD MONEY until tomorrow. They lost the Target business, but he said that is only 2% of their business. The company doesn’t use high-fructose…
Cramer Diagnoses Quest Diagnostics (DGX)
Cramer’s last Fallen Angel on CNBC’s MAD MONEY tonight was Quest Diagnostics (DGX-NYSE). He owns it in his trust, for disclosure. He said that Quest losing Oxford’s business (Unitedhealth-UNH) took the stock down under…
Cramer Defends Amgen (AMGN)
Another ‘Fallen Angel’ from Cramer on CNBC’s MAD MONEY is Amgen (AMGN-NASDAQ) after it got crushed last week. He said this is much to do about nothing. The headline risk was that Aranesp was…
Cramer Positive on VF Corp (VFC)
Tonight on CNBC’s MAD MONEY, Cramer said that VF Corp (VFC-NYSE) is one of his fallen angels because last week lost 7% on the guidance coming in light after it sold off a low-margin…
Krispy Kreme Current in SEC Filings; Now What?
Krispy Kreme Doughnuts, Inc. (KKD-NYSE) announced today that it has finally become current in its SEC Filings: Form 10-Q for Q1 2004 and Q3 2005 fiscal year; filing follows the filings of the Company’s…
Market Wrap (JAN 29, 2007)
Stocks in the news today; followed by Stock Ticker, closing price, and net price change. DJIA 12,490.78; Up 3.76 (0.03%)NASDAQ 2,441.09; Up 5.60 (0.23%)S&P500 1,420.62; Down 1.56 (0.11%)10YR-Bond 4.8920%; Up…
Cramer Slaps Wal-Mart; Still Loves Allegheny Tech
On today’s STOP TRADING segment on CNBC, Cramer said Kroger (KR) is a play. With Kroger at $29 after a B of A upgrade said it could beat for years to come. The case…
Cramer: Bush is Hurting the Market Multiple; Also Comments on Gap & Home Depot
Today Cramer was dissecting some deal making on his Wall Street Confidential on TheStreet.com. Cramer said today’s strength in slow sectors is from M&A. Online Education and Paper sectors have been dead, Bristol-Myers (BMY)…
Bristol-Myers’ Buyout Price? $28.35 Or Less to Options Prices
The talk of IF Bristol-Myers Squibb (BMY-NYSE) is really going to be gobbled up by Sanofi-Aventis (SNY-NYSE/ADR) hasn’t gone away, but the dust is settling. We covered the ‘media reports’ and what it would…
AMD, Intel Price War Revisited
By Chad Brand of The Peridot Capitalist I wrote about the battle in the microprocessor market between Advanced Micro Devices (AMD) and market leader Intel (INTC) twice during 2006 (link: semiconductors category archive) and…
Comparing Fourth Quarter Earnings
From Ticker Sense With over 33% of S&P 500 companies reporting this earnings season, the percentage of companies beating estimates now stands at 69% compared to the 60% we saw early last week. The…